Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
about
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpretedAdvanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancerPrognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenograftsPrognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer.Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidatesPrognostic factors in resected lung carcinomas.Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma.Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast CancerCorrelation between (18)f-fluorodeoxyglucose uptake and epidermal growth factor receptor mutations in advanced lung cancerFDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary reportDemonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PETTumor bioenergetics: an emerging avenue for cancer metabolism targeted therapyThe maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancerCorrelation of PET/CT standardized uptake value measurements between dedicated workstations and a PACS-integrated workstation systemImaging and cancer: a review.Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.Imaging response assessment in oncologyProspective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical ImplicationsFDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.Distance in cancer gene expression from stem cells predicts patient survival.Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancerThe prognostic value of PET and PET/CT in cervical cancerPositron emission tomography imaging as a cancer biomarker.High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications.Predictive and prognostic value of FDG-PET.Warburg revisited: imaging tumour blood flow and metabolism.Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer.Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.
P2860
Q24652381-388C789C-FC2D-48A7-8A07-699C5E86D51CQ27025770-D76C9D52-40D1-497E-97CB-30F129291538Q28081159-1F07E3A5-2F19-41E5-8591-7D8C5462EA3DQ28484852-BA8AFF4D-9843-4FE4-B1D7-C8E750989A79Q33626863-02667DA0-6E87-46BA-813F-EF15156C11A3Q33639144-864596EB-CB61-4244-8C89-8A632E6A1F2AQ33697964-3FADD7D7-F8BD-487D-9BE2-5193C66929CAQ33704212-7A7F0EC2-CA3E-49F3-9922-5995642F3203Q33704435-49AEA1C0-D7C8-4A75-A581-4C97F42A3582Q33704537-A14FDF40-E923-482E-AB17-1BE89A387A03Q33724626-F24FF1DC-42EB-4E54-BD34-3456F9CFF76EQ33751205-E62F895D-8437-4DEB-86C3-D6B12291820BQ33762689-49C8298F-EC3F-4F57-BDEC-F924BF762651Q33918475-F44D034A-11EE-4715-A12A-61D2A554F56CQ34179999-31A8AF39-FEC0-4A7D-AACA-1E6ADE2D0DB3Q34569318-8D64055C-000B-4369-BAC1-891F2B75503FQ34599293-8EAB59BE-B42B-4B44-BDF4-B67C9E09D9C6Q34977050-1A89F1CB-2E8C-4744-8C9B-C515C04DBB1CQ35240586-DB109C50-532D-48A1-8C3D-E52D7CF7776BQ35332601-22F5AD99-99FE-4370-B117-BE5A291E0C4EQ35613319-FD116379-7CC1-4C8E-A75A-9BC33DA59051Q35650697-D6118F5A-278A-4AFA-A653-9D054DF0CE62Q35761121-24B4B5D0-B3DE-4BB6-9C94-BA705DC0795AQ35873227-D5FA068A-29CC-4D20-A139-96EBDF61BD37Q35915703-0640C925-C03D-4DE7-8D63-60C64B78C868Q35917780-D8AA1844-2692-419C-B937-6BBF5E764718Q36195043-DA02706B-5EF4-4D1E-A7BA-849540587CB7Q36285794-9ABBDA9E-E276-4369-A8D5-B56F5D6A87C6Q36319754-B0F97FA2-89D0-4B59-8271-E6C15A86BA56Q36410337-9A498449-CACE-40FF-95A0-FA0E5976CBB2Q36467475-8782EB50-CED9-442B-AAD5-2CA470DF714AQ36602216-4F9D18C7-0139-4D07-99C0-D987C6022A8EQ36836254-05D1B589-30C6-46D0-A4EC-81FE29B00C1CQ36950458-DDDA7880-29A6-4A03-85BB-680064EC16B9Q36952692-AFDF1410-B4A0-40BC-A4D1-47B38BD947A5Q37063199-D44F3405-88A4-4CC3-BE64-043D5D546916Q37129057-91B2EA9B-A7B1-43F1-B3C5-02740413EE04Q37129062-01062DE1-7960-4FE2-8543-14EB98E66A6EQ37158479-9D7D730B-F799-45B4-AD57-04E2243BEDEFQ37178855-E41FEF83-66AF-442A-8554-6DE8BE2CE342
P2860
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Preoperative F-18 fluorodeoxyg ...... l after lung cancer resection.
@ast
Preoperative F-18 fluorodeoxyg ...... l after lung cancer resection.
@en
type
label
Preoperative F-18 fluorodeoxyg ...... l after lung cancer resection.
@ast
Preoperative F-18 fluorodeoxyg ...... l after lung cancer resection.
@en
prefLabel
Preoperative F-18 fluorodeoxyg ...... l after lung cancer resection.
@ast
Preoperative F-18 fluorodeoxyg ...... l after lung cancer resection.
@en
P2093
P356
P1476
Preoperative F-18 fluorodeoxyg ...... al after lung cancer resection
@en
P2093
Alain Vincent
Manjit S Bains
Mithat Gonen
Robert J Downey
Steven Larson
Timothy Akhurst
P304
P356
10.1200/JCO.2004.11.109
P407
P577
2004-08-01T00:00:00Z